triiodothyronine has been researched along with angiotensin ii, des-phe(8)- in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barreto-Chaves, MLM; Campagnole-Santos, MJ; Diniz, GP; Melo, MB; Santos, RAS; Senger, N | 1 |
| Akamine, EH; Barreto-Chaves, MLM; C Parletta, A; Campagnole-Santos, MJ; Diniz, GP; Marques, BVD; Santos, RAS; Senger, N | 1 |
2 other study(ies) available for triiodothyronine and angiotensin ii, des-phe(8)-
| Article | Year |
|---|---|
Angiotensin-(1-7) reduces cardiac effects of thyroid hormone by GSK3Β/NFATc3 signaling pathway.
Topics: Angiotensin I; Animals; Cardiomegaly; Cells, Cultured; Echocardiography; Glycogen Synthase Kinase 3 beta; Hyperthyroidism; Male; Myocytes, Cardiac; NFATC Transcription Factors; Peptide Fragments; Rats, Sprague-Dawley; Rats, Transgenic; Rats, Wistar; Renin-Angiotensin System; Signal Transduction; Triiodothyronine | 2018 |
Angiotensin-(1-7) prevents T3-induced cardiomyocyte hypertrophy by upregulating FOXO3/SOD1/catalase and downregulating NF-ĸB.
Topics: Angiotensin I; Animals; Antioxidants; Catalase; Down-Regulation; Forkhead Box Protein O3; Hypertrophy; Male; Models, Biological; Myocytes, Cardiac; NF-kappa B; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Rats, Transgenic; Rats, Wistar; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Superoxide Dismutase-1; Triiodothyronine; Up-Regulation | 2021 |